Active Ingredient: LAMIVUDINE
Proprietary Name: LAMIVUDINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211306
Product Number: 001
Approval Date: Mar 21, 2019
Applicant Holder Full Name: ANNORA PHARMA PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information